In a study of 526 patients with localized brain injuries, researchers discovered two distinct brain networks that impact depression symptoms. The findings may open up new avenues for researchers to investigate neuromodulation therapy as a treatment for depression.
The researchers looked at the locations of patients’ brain lesions about their depression symptoms as determined by the Beck Inventory Assessment. The authors identified “risk” and “resilience” regions using this data.
The findings may pave the way for new treatments that modulate specific brain areas, such as transcranial magnetic field therapy (TMS), or non-invasive forms of stimulation, such as electroshock therapy. According to a study, people with depression are more vulnerable to risk and resilience in areas of the brain associated with reflective thinking.
Neuromodulation therapies have the potential to be a viable alternative to pharmacological treatments. Proper targeting is the key to developing effective therapies. Information that assists stakeholders in understanding the brain science behind depression symptoms will almost certainly play an important role in this development.
Source: Radiology Business
Name of Author: Jessica Kania